BioLeap Names Keith Mackay as Vice President for Sales in Next Step to Further Commercialize Novel Molecular Design

EWING, N.J.--(BUSINESS WIRE)--BioLeap, Inc. today announced the appointment of Keith Mackay as Vice President, Sales, in a further step toward the successful commercialization of the company’s novel molecular-design technology.

MORE ON THIS TOPIC